Clinical Trial Update: Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating probenecid as a novel treatment to alleviate symptoms of opioid withdrawal, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Drugs mentioned

• Probenecid (probenecid)

Snippet

Sponsor: University of Calgary | Conditions: Chronic Pain, Drug Dependence of Morphine Type | Phase 2 | Status: RECRUITING